6533b82afe1ef96bd128ba43

RESEARCH PRODUCT

A Microscopic Description of SARS-CoV-2 Main Protease Inhibition with Michael Acceptors. Strategies for Improving Inhibitors Design

Carlos A. Ramos-guzmánIñaki TuñónJ. Javier Ruiz-pernía

subject

0303 health sciencesReaction mechanismProteasebiologyStereochemistryChemistrymedicine.medical_treatmenteducationActive siteSubstrate (chemistry)General Chemistry010402 general chemistry01 natural sciences0104 chemical sciencesQM/MM03 medical and health sciencesChemistryMolecular dynamicsScissile bondCovalent bondmedicinebiology.proteinMichael reaction030304 developmental biology

description

The irreversible inhibition of the main protease of SARS-CoV-2 by a Michael acceptor known as N3 has been investigated using multiscale methods. The noncovalent enzyme–inhibitor complex was simulated using classical molecular dynamics techniques and the pose of the inhibitor in the active site was compared to that of the natural substrate, a peptide containing the Gln–Ser scissile bond. The formation of the covalent enzyme–inhibitor complex was then simulated using hybrid QM/MM free energy methods. After binding, the reaction mechanism was found to be composed of two steps: (i) the activation of the catalytic dyad (Cys145 and His41) to form an ion pair and (ii) a Michael addition where the attack of the Sγ atom of Cys145 to the Cβ atom of the inhibitor precedes the water-mediated proton transfer from His41 to the Cα atom. The microscopic description of protease inhibition by N3 obtained from our simulations is strongly supported by the excellent agreement between the estimated activation free energy and the value derived from kinetic experiments. Comparison with the acylation reaction of a peptide substrate suggests that N3-based inhibitors could be improved by adding chemical modifications that could facilitate the formation of the catalytic dyad ion pair.

https://doi.org/10.26434/chemrxiv.12895064.v1